Affiliation:
1. Department of Obstetrics and GynecologyWuhan Children’ Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science&Technology, Wuhan Hubei Province430016 P.R. China
2. Department of Obstetrics and Gynecology1st Affiliated Hospital of Wenzhou Medical UniversityWenzhou Zhejiang Province325035 P.R.China
3. Department of Obstetrics and Gynecology of traditional Chinese Medicine, Wenzhou People’s Hospital, Wenzhou Zhejiang Province325000 P.R. China
4. No. 57 Canghou Street Lucheng DistrictWenzhou City Zhejiang Province325699 P.R.China
Abstract
AbstractObjectiveTo evaluate the diagnostic value of combination detection of serum cancer antigen 125 (CA125), carbohydrate antigen 19-9 (CA199) and carci noembryonic antigen(CEA) in patients with epithelial ovarian cancer by pooling the open published studies according to meta-analysis method.MethodsDiagnostic studies related to combination detection of serum CA125, CA199 and CEA in patients with epithelial ovarian cancer were electronic searched in the databases of PubMed, Cochrane, Google scholar, EMBASE, ISI Web of Knowledge and CNKI by two independent reviewers. The combined diagnostic sensitivity, specificity, positive likely hood ratio (+LR), negative likely hood ratio (-LR), diagnostic odds ratio (DOR), and area under the receiver operating characteristic curve (AUC) were pooled by Med DiSc1.4 software.ResultsTwelve prospective diagnostic publications were finally fulfilled the inclusion criteria and were included in this meta-analysis. The pooled diagnostic sensitivity specificity, positive likely hood ratio, negative likely hood ratio, diagnostic odds ratio, and AUC were 0.90 (95%CI: 0.80 to 0.92), 0.83 (95%CI: 0.80 to 0.86), 5.35(95%CI:3.90 to 7.33), 0.13 (95%CI: 0.10 to 0.16), 48.53 (95%CI: 29.91 to 78.72) and 0.92 (95%C: 0.89 to 0.94) respectively by fixed or random effect model. No publication bias was found according to the funnel plot and line regression test (t=-1.34, P=0.21).ConclusionCombination detection serum CA125, CA199 and CEA was a promising biomarker forepithelial ovarian cancer diagnosis with relative high sensitivity and specificity.
Reference18 articles.
1. Clinical evaluation serum CA CEA and CA combined detection for ovarian cancer diagnosis West China Medical;Pu;Journal,2010
2. CA as a marker for ovarian cancer : alone and in comparison with CA;Canney;Cancer,1985
3. Combination detection serum CA CA and CEA for ovarian cancer diagnosis Journal of Radioimmunology Diagnostic value for combined detection serum CA CA and CEA in patients with ovarian cancer of Henan University ( Medical;Shao;Journal Science,2007
4. Ovarian Cancer Screening Tests Don t Pass Muster;Voelker;JAMA,2016
5. CA : the past and the uture;Bast;Int J Biol Markers,1998
Cited by
47 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献